Ruddy S, Austen K F, Goetzl E J
J Clin Invest. 1975 Mar;55(3):587-92. doi: 10.1172/JCI107966.
Interaction of D (the activated form of D) and B, factors of the properdin pathway, with C3b (the major cleavage fragment of C3) generates a convertase, C3B, which cleaves C3 and initiates the terminal complement sequence C5-C9. A functionally analogous more stable C3 convertase, CoVFB, ir formed by substituting cobra venom factor (CoVF) for C3b. Mixtures of highly purified CoVF, B, and D were chemotactic for human neutrophil polymorphonuclear leukocytes as assessed in Boyden chambers either by microscopic enumeration of migrating cells or by counting of 51Cr-labeled cells. Control mixtures containing CoVF, B, and D, reacted in the absence of Mg++, were hemolytically inactive and devoid of chemotactic activity. Over a range of doses, the chemotactic activity of mixtures yielding CoVFB correlated with their hemolytic activity. Pretreatment of neutrophils with mixtures containing CoVFB rendered them unresponsive to subsequent chemotactic stimulation by kallikrein of C5a, indicating cross-deactivation to other chemotactic factors. Similar neutrophil deactivation occurred after exposure to a mixture of C3b, B, and D in which C3B was formed; with short incubation times and high cell concentration C3B also exhibited some chemotactic activity. The chemotactic activity of C3B and CoVFB is an example of a biologic function arising from interactions among factors of the properdin pathway per se, as distinguished from the capacity of this pathway to activate C3 and the terminal complement sequence.
补体旁路途径中的D(D的活化形式)和B因子与C3b(C3的主要裂解片段)相互作用产生一种转化酶C3B,它裂解C3并启动终末补体序列C5 - C9。一种功能类似但更稳定的C3转化酶CoVFB,是通过用眼镜蛇毒因子(CoVF)替代C3b形成的。在Boyden小室中,通过显微镜计数迁移细胞或计数51Cr标记的细胞评估,高度纯化的CoVF、B和D的混合物对人中性粒细胞多形核白细胞具有趋化作用。不含Mg++时反应的含CoVF、B和D的对照混合物无溶血活性且无趋化活性。在一系列剂量范围内,产生CoVFB的混合物的趋化活性与其溶血活性相关。用含CoVFB的混合物预处理中性粒细胞,使其对随后激肽释放酶或C5a的趋化刺激无反应,表明对其他趋化因子存在交叉失活。暴露于形成C3B的C3b、B和D的混合物后,中性粒细胞也会发生类似的失活;在短孵育时间和高细胞浓度下,C3B也表现出一定的趋化活性。C3B和CoVFB的趋化活性是补体旁路途径因子本身相互作用产生的生物学功能的一个例子,这与该途径激活C3和终末补体序列的能力不同。